Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

456 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prognostic Impact and Risk Factors of Infections in Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib.
Mauro FR, Giannarelli D, Visentin A, Reda G, Sportoletti P, Frustaci AM, Chiarenza A, Ciolli S, Vitale C, Laurenti L, De Paoli L, Murru R, Gentile M, Rigolin GM, Levato L, Giordano A, Del Poeta G, Stelitano C, Ielo C, Noto A, Guarente V, Molica S, Coscia M, Tedeschi A, Gaidano G, Cuneo A, Foà R, Martelli M, Girmenia C, Gentile G, Trentin L. Mauro FR, et al. Among authors: noto a. Cancers (Basel). 2021 Jun 29;13(13):3240. doi: 10.3390/cancers13133240. Cancers (Basel). 2021. PMID: 34209515 Free PMC article.
Reply to "CLL and COVID-19 at the Hospital Clinic of Barcelona: an interim report" Analysis of six hematological centers in Lombardy : On behalf of CLL commission of Lombardy Hematology Network (REL).
Reda G, Noto A, Cassin R, Zamprogna G, Borella C, Scarfò L, Farina L, Molteni A, Ghia P, Tedeschi A, Montillo M; Rete Ematologica Lombarda (REL) Clinical Network. Reda G, et al. Among authors: noto a. Leukemia. 2020 Sep;34(9):2531-2532. doi: 10.1038/s41375-020-0966-y. Epub 2020 Aug 4. Leukemia. 2020. PMID: 32753689 Free PMC article. No abstract available.
Prediction of outcomes in chronic lymphocytic leukemia patients treated with ibrutinib: Validation of current prognostic models and development of a simplified three-factor model.
Molica S, Giannarelli D, Visentin A, Reda G, Sportoletti P, Frustaci AM, Chiarenza A, Ciolli S, Vitale C, Laurenti L, De Paoli L, Murru R, Gentile M, Moia R, Rigolin GM, Levato L, Giordano A, Del Poeta G, Stelitano C, Deodato M, Ielo C, Noto A, Guarente V, Coscia M, Tedeschi A, Gaidano G, Cuneo A, Foa' R, Trentin L, Mauro FR. Molica S, et al. Among authors: noto a. Am J Hematol. 2022 May;97(5):E176-E180. doi: 10.1002/ajh.26502. Epub 2022 Feb 25. Am J Hematol. 2022. PMID: 35170793 Free article. No abstract available.
Ibrutinib in patients over 80 years old with CLL: a multicenter Italian cohort.
Reda G, Mattiello V, Frustaci AM, Visentin A, Mauro FR, Innocenti I, Gentile M, Giannarelli D, Noto A, Cassin R, Neri A, Laurenti L, Tedeschi A. Reda G, et al. Among authors: noto a. Blood Adv. 2023 Feb 28;7(4):525-528. doi: 10.1182/bloodadvances.2022007619. Blood Adv. 2023. PMID: 35930765 Free PMC article. No abstract available.
Ensuring continuity of care of hematologic patients during COVID-19 pandemic in a tertiary hospital in Lombardy (Italy).
Fattizzo B, Giannotta JA, Barcellini W, Barbanti MC, Bucelli C, Cassin R, Cattaneo D, Cavallaro F, Ferla V, Fracchiolla NS, Freyrie A, Galassi G, Goldaniga MC, Grifoni FI, Iurlo A, Mangiameli G, Mattiello V, Meli M, Neri A, Noto A, Onida F, Ottani L, Pasquale R, Pettine L, Pompa A, Reda G, Rossi FG, Saporiti GN, Sciumè M, Tagliaferri E, Baldini L. Fattizzo B, et al. Among authors: noto a. Blood Adv. 2020 Jul 14;4(13):2996-2999. doi: 10.1182/bloodadvances.2020002120. Blood Adv. 2020. PMID: 32609844 Free PMC article. No abstract available.
456 results